Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

How Much Will The Genital Warts Market Be Worth By 2029?

In recent times, a steady increase has been observed in the genital warts market size. The market, that was worth $1.97 billion in 2024, is expected to reach a value of $2.06 billion the following year, exhibiting a compound annual growth rate (CAGR) of 4.7%. The surge during the historical period is believed to be due to heightened attention towards patient-oriented healthcare, earlier detection and treatment, broader accessibility of self-targeted therapies, and a rise in the number of clinical tests as well as instances of genital warts recurrence.

In the coming years, the genital warts market is predicted to experience significant growth, reaching a value of $2.52 billion in 2029 with a compound annual growth rate (CAGR) of 5.1%. The expected growth within the forecast period can be credited to various factors like the embracement of telemedicine and digital health platforms for remote consultations and monitoring of treatment procedures, increasing need for affordable and effective treatments for sexually transmitted infections, the rising popularity of loop electrosurgical excision procedures, mounting demand for interferon alfa-n3 injections along with the growing availability of treatments. The forecast period also highlights key trends including technological advancement in diagnosing, a shift towards the usage of combined therapies, the growth of telehealth and online consultation services, the development of new therapeutic targets, as well as the growing expansion in emerging markets.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18374&type=smp

Which Key Factors Are Fueling Growth In The Genital Warts Market?

The escalating occurrence of sexually transmitted infections (STIs) acts as a catalyst for the expansion of the genital warts market. Sexually transmitted infections (STIs), primarily spread through sexual intercourse, including vaginal, anal and oral, are triggered by pathogens like bacteria, viruses or parasites. The increased number of STIs globally is a result of factors such as rising sexual activity, insufficient use of protection and inadequate access to both educational and medical facilities. Specific strains of the human papillomavirus (HPV) cause genital warts, which is a common sexually transmitted infection (STI). Skin-to-skin contact during sexual intercourse spreads these. For instance, data from the Joint United Nations Programme on HIV/AIDS, based in Switzerland, exhibit that nearly 38.7 million people were HIV positive in 2021. This number escalated to 39.0 million in 2022, with a startling addition of 1.3 million individuals newly infected in the same year. Consequently, the surge in the incidence of sexually transmitted infections (STIs) is propelling the development of the genital warts market.

Which Segmentation Factors Are Critical In The Genital Warts Market Analysis?

The genital wartsmarket covered in this report is segmented –

1) By Drug Type: Imiquimod; Podophyllin; Podofilox; Trichloroacetic Acid

2) By Treatment: Chemical Treatment; Ablative Treatment; Preventive Treatment; Other Treatments

3) By Gender: Female; Male

4) By End Users: Hospitals; Clinics; Home Care Settings

Subsegments:

1) By Imiquimod: Imiquimod Cream 5%; Imiquimod Cream 3.75%

2) By Podophyllin: Podophyllin Resin 10%; Podophyllin Resin 25%

3) By Podofilox: Podofilox Gel 0.5%; Podofilox Solution 0.5%

4) By Trichloroacetic Acid: Trichloroacetic Acid 80-90%; Trichloroacetic Acid 50-70%

What Are The Dominant Trends Currently Seen In The Genital Warts Market?

Leading enterprises in the genital warts market are advancing new treatment choices such as innovative dermatology drugs, aiming to tackle the problems experienced by genital warts patients. Dermatology drugs are cutting-edge pharmaceuticals or therapeutic products exclusively created for managing various dermatologic conditions including genital warts. For example, in March 2023, Verrica Pharmaceuticals Inc., a dermatology pharmaceutical firm based in the US, earned New Chemical Entity (NCE) status for its drug candidate called YCANTH. YCANTH, which is currently under development for treating genital warts, has completed phase 2 trials. The FDA NCE status provides the company with a minimum of five years shield against generic competition.

Which Players Are Shaping The Competitive Landscape Of The Genital Warts Market?

Major companies operating in the genital warts market are Merck & Co.Inc., AbbVie Inc, Sanofi S.A, Novartis AG, 3M Company, Teva Pharmaceutical Industries Ltd, Bausch Health Companies Inc, Sun Pharmaceuticals, Perrigo Company plc, Glenmark Pharmaceutical Inc, Taro Pharmaceutical Industries Ltd, Serum Institute of India Pvt. Ltd., ANI Pharmaceuticals Inc, Ligand Pharmaceuticals Incorporated, Orgenesis Inc, Verrica Pharmaceuticals Inc, CryoConcepts LP, CryoIQ global AB, Cassiopea Inc, Aresus Pharma Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/genital-warts-global-market-report

Which Region Is Likely To Register The Fastest Growth In The Genital Warts Market?

North America was the largest region in the genital warts market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genital warts market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=18374&type=smp

Browse Through More Reports Similar to the Global Genital Warts Market 2025, By The Business Research Company

Cryogenic Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cryogenic-equipment-global-market-report

Cryogenic Pump Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cryogenic-pump-global-market-report

Cryogenic Insulation Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cryogenic-insulation-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model